<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.emaxhealth.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Eye and Vision</title>
 <link>http://www.emaxhealth.com/96</link>
 <description>The taxonomy view for health categories</description>
 <language>en</language>
<item>
 <title>Prevention, Eyecare Begin At Home</title>
 <link>http://www.emaxhealth.com/2/96/27091/prevention-eyecare-begin-home.html</link>
 <description>&lt;p&gt;How exposed are your eyes to harmful UV rays? Are you aware of the damaging effects? Do you remember the date of your next eye appointment? Do you know where the closest eyecare professional is located? Find the answers to these questions and more information about eye health from the comfort of your home by visiting &lt;a href=&quot;http://www.Transitions.com&quot; title=&quot;www.Transitions.com&quot;&gt;www.Transitions.com&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Over 56 percent of Hispanics in the United States use the Internet for recreational purposes or to find information and carry out business. Therefore, it&#039;s no surprise that Hispanics also search online to learn more about eye health.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/2/96/27091/prevention-eyecare-begin-home.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/2/96/27091/prevention-eyecare-begin-home.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <pubDate>Mon, 01 Dec 2008 23:00:38 -0600</pubDate>
 <dc:creator>ruzik_tuzik</dc:creator>
 <guid isPermaLink="false">27091 at http://www.emaxhealth.com</guid>
</item>
<item>
 <title>Melantonin May Be A Successful Uveitis Treatment</title>
 <link>http://www.emaxhealth.com/1020/96/26841/melantonin-may-be-successful-uveitis-treatment.html</link>
 <description>&lt;p&gt;Uveitis is a sudden inflammation of the eye that can cause blindness in 10 to 15% of cases. Research now suggests that melatonin can successfully treat the inflammatory changes that occur with uveitis, and protect the eye from damage. The findings on melantonin and Uveitis treatment appear in the December 2008 issue of The American Journal of Pathology.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/1020/96/26841/melantonin-may-be-successful-uveitis-treatment.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/1020/96/26841/melantonin-may-be-successful-uveitis-treatment.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <pubDate>Sun, 23 Nov 2008 08:02:18 -0600</pubDate>
 <dc:creator>Kathleen Blanchard RN</dc:creator>
 <guid isPermaLink="false">26841 at http://www.emaxhealth.com</guid>
</item>
<item>
 <title>Speeding Up Eye Treatment</title>
 <link>http://www.emaxhealth.com/2/96/26585/speeding-eye-treatment.html</link>
 <description>&lt;p&gt;Nine treatment centres will be established across Wales to help ensure faster, fairer treatment for patients at risk of losing their sight, Health Minister Edwina Hart announced today.&lt;/p&gt;
&lt;p&gt;It follows a review of current arrangements by Local Health Boards for delivering treatment for wet age-related macular degeneration (AMD). Wet AMD is the primary cause of sight loss in the UK.&lt;/p&gt;
&lt;p&gt;Last June, Mrs Hart announced that the NHS in Wales would fund Lucentis treatment for first and second eye patients with wet AMD.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/2/96/26585/speeding-eye-treatment.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/2/96/26585/speeding-eye-treatment.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <pubDate>Mon, 17 Nov 2008 01:48:59 -0600</pubDate>
 <dc:creator>ruzik_tuzik</dc:creator>
 <guid isPermaLink="false">26585 at http://www.emaxhealth.com</guid>
</item>
<item>
 <title>NEI Completes Age-Related Eye Disease Study</title>
 <link>http://www.emaxhealth.com/2/96/26347/nei-completes-age-related-eye-disease-study.html</link>
 <description>&lt;p&gt;The National Eye Institute (NEI), part of the National Institutes of Health (NIH), announces the release of more than 10 years of data collected during the Age-Related Eye Disease Study (AREDS), which looked at the progression of age-related macular degeneration and age-related cataract in 4,757 adults aged 55 to 80.&lt;/p&gt;
&lt;p&gt;Researchers around the world can apply for access to this complete set of medical history records and clinical trial results as well as select genetic information to gain a better understanding of two complicated vision conditions that affect aging adults.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/2/96/26347/nei-completes-age-related-eye-disease-study.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/2/96/26347/nei-completes-age-related-eye-disease-study.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <pubDate>Mon, 10 Nov 2008 10:08:45 -0600</pubDate>
 <dc:creator>ruzik_tuzik</dc:creator>
 <guid isPermaLink="false">26347 at http://www.emaxhealth.com</guid>
</item>
<item>
 <title>Contamination of Contact Lens Storage Cases of Refractive Surgery Candidates</title>
 <link>http://www.emaxhealth.com/1/96/26341/contamination-contact-lens-storage-cases-refractive-surgery-candidates.html</link>
 <description>&lt;p&gt;Millions of people around the world wear contact lenses, with 24 million wearers in the U.S. alone. While contact lens care is generally very safe, lenses that are not properly cleaned and disinfected increase the risk of severe eye infection. Any lens that is removed from the eye needs to be cleaned and disinfected before it is reinserted. &lt;/p&gt;
&lt;p&gt;Care of contact lenses includes cleaning the storage case, since it is a potential source of infection.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/1/96/26341/contamination-contact-lens-storage-cases-refractive-surgery-candidates.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/1/96/26341/contamination-contact-lens-storage-cases-refractive-surgery-candidates.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <pubDate>Mon, 10 Nov 2008 08:08:41 -0600</pubDate>
 <dc:creator>hareyan</dc:creator>
 <guid isPermaLink="false">26341 at http://www.emaxhealth.com</guid>
</item>
<item>
 <title>Corneal Collagen Crosslinking: Treatment Results in Keratoconus Patients</title>
 <link>http://www.emaxhealth.com/1/96/26315/corneal-collagen-crosslinking-treatment-results-keratoconus-patients.html</link>
 <description>&lt;p&gt;&lt;strong&gt;Keratoconus&lt;/strong&gt; is an eye disorder that causes corneal tissue to become abnormally thin and the central area to protrude in a cone shape, distorting vision. The cornea is the clear tissue that covers the front of the eye and is crucial to focusing light on the back of the eye. In the US, keratoconus occurs in 50 to200 per 100,000 people; reported rates vary with the criteria used for diagnosis. Unofficial reports indicate this disorder may be more prevalent in the Indian subcontinent, Arabia, and New Zealand.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/1/96/26315/corneal-collagen-crosslinking-treatment-results-keratoconus-patients.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/1/96/26315/corneal-collagen-crosslinking-treatment-results-keratoconus-patients.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <pubDate>Sun, 09 Nov 2008 08:49:05 -0600</pubDate>
 <dc:creator>hareyan</dc:creator>
 <guid isPermaLink="false">26315 at http://www.emaxhealth.com</guid>
</item>
<item>
 <title>Plasma Interleukin 6 as a Potential Biomarker of Age-related Macular Degeneration (AMD) </title>
 <link>http://www.emaxhealth.com/1/96/26314/plasma-interleukin-6-potential-biomarker-age-related-macular-degeneration-amd.html</link>
 <description>&lt;p&gt;In its advanced stages, Age-related Macular Degeneration destroys the detailed, central vision we need to read, drive, recognize faces, and enjoy daily life, and is a major cause of vision loss in the U.S. Ophthalmic researchers are making rapid progress in understanding how genetics, immune system factors, nutrition choices, and other variables interact to produce or prevent Age-related Macular Degeneration.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/1/96/26314/plasma-interleukin-6-potential-biomarker-age-related-macular-degeneration-amd.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/1/96/26314/plasma-interleukin-6-potential-biomarker-age-related-macular-degeneration-amd.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <pubDate>Sun, 09 Nov 2008 08:47:35 -0600</pubDate>
 <dc:creator>hareyan</dc:creator>
 <guid isPermaLink="false">26314 at http://www.emaxhealth.com</guid>
</item>
<item>
 <title>Could Religious Beliefs Affect Compliance with Ocular Treatment?</title>
 <link>http://www.emaxhealth.com/1/96/26313/could-religious-beliefs-affect-compliance-ocular-treatment.html</link>
 <description>&lt;p&gt;For people of strong faith, religious beliefs and related cultural taboos can have a powerful impact on how they care for their health, including the medical treatments they choose to accept. Increasingly, ophthalmologists (Eye M.D.s) in the US and other countries, care for patients of diverse backgrounds. This is accelerating the need for reliable information on the interaction of religious beliefs and compliance with prescribed vision treatments.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/1/96/26313/could-religious-beliefs-affect-compliance-ocular-treatment.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/1/96/26313/could-religious-beliefs-affect-compliance-ocular-treatment.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <category domain="http://www.emaxhealth.com/9">Spirituality and Healing</category>
 <pubDate>Sun, 09 Nov 2008 08:45:38 -0600</pubDate>
 <dc:creator>hareyan</dc:creator>
 <guid isPermaLink="false">26313 at http://www.emaxhealth.com</guid>
</item>
<item>
 <title>Damage to Optic Nerve in Glaucoma Patients May Indicate Carotid Artery Narrowing</title>
 <link>http://www.emaxhealth.com/1/96/26312/damage-optic-nerve-glaucoma-patients-may-indicate-carotid-artery-narrowing.html</link>
 <description>&lt;p&gt;Glaucoma is often associated with elevated pressure inside the eye (intraocular pressure, or IOP) which can damage the optic nerve, leading to vision loss and even blindness. Medication and/or surgery allow patients to control their IOP, thus &lt;strong&gt;preventing the development of vision loss&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/1/96/26312/damage-optic-nerve-glaucoma-patients-may-indicate-carotid-artery-narrowing.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/1/96/26312/damage-optic-nerve-glaucoma-patients-may-indicate-carotid-artery-narrowing.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <pubDate>Sun, 09 Nov 2008 08:43:17 -0600</pubDate>
 <dc:creator>hareyan</dc:creator>
 <guid isPermaLink="false">26312 at http://www.emaxhealth.com</guid>
</item>
<item>
 <title>New C-VUE Advanced Custom Toric Lens Launched</title>
 <link>http://www.emaxhealth.com/2/96/26234/new-c-vue-advanced-custom-toric-lens-launched.html</link>
 <description>&lt;p&gt;Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the launch of the all new C-VUE Advanced Custom Toric. The C-VUE Advanced Custom Toric will be sold directly to independent eye care professionals and features a revolutionary trial program, an advanced hydration material and exceptional deliverability (typically ships within in 2 to 3 days).&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.emaxhealth.com/2/96/26234/new-c-vue-advanced-custom-toric-lens-launched.html&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.emaxhealth.com/2/96/26234/new-c-vue-advanced-custom-toric-lens-launched.html#comments</comments>
 <category domain="http://www.emaxhealth.com/96">Eye and Vision</category>
 <pubDate>Thu, 06 Nov 2008 00:01:01 -0600</pubDate>
 <dc:creator>ruzik_tuzik</dc:creator>
 <guid isPermaLink="false">26234 at http://www.emaxhealth.com</guid>
</item>
</channel>
</rss>
